Opioid Addiction Medication Assisted Treatment: Part 1

Published April 6, 2013

Opioid Addiction Medication Assisted Treatment: Part 1 – Trusandra Taylor, MD, FASAM, MPH and Charles Morgan, MD, FASAM, FAAFP present “Opioid Addiction Medication Assisted Treatment: Part 1: Clinical Pharmacology,…

BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented …

Filed under: buprenorphine treatment

Additionally, BDSI is developing a high dose formulation of buprenorphine in combination with naloxone for the treatment of opioid dependence. The product, which has been known as BEMA Buprenorphine/Naloxone, or BNX, will be marketed in the U.S. …
Read more on PR Newswire (press release)